Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beta interferon
Open Access
- 1 May 1990
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 64 (5) , 2187-2192
- https://doi.org/10.1128/jvi.64.5.2187-2192.1990
Abstract
BALB/c mice infected on the scarified cornea with herpes simplex virus type 1 strain 35 [HSV-1(35)] rarely developed ocular disease even at challenge doses as high as 10(7) PFU per eye. In contrast, HSV-1(RE) consistently induced stromal keratitis at an inoculum of 2 x 10(4) PFU. The goal of this study was to determine the reason for the difference in virulence between the two HSV strains. Both HSV-1 strains replicated to similar titers in excised corneal "buttons." However, after in vivo infection of the cornea, the growth of strain 35 was evident only during the first 24 h postinfection, whereas the replication of strain RE persisted for at least 4 days. In vitro tests revealed that HSV-1(35) was greater than 10 times more sensitive to alpha/beta interferon (IFN-alpha/beta) than HSV-1(RE). Both strains induced comparable serum levels of IFN after intraperitoneal inoculation. The kinetics of HSV-1(35) clearance from the eye was markedly altered by treatment with rabbit anti-IFN-alpha/beta. Virus titers exceeding 10(4) PFU per eye could be demonstrated 4 to 5 days postinfection in mice given a single inoculation of antiserum 1 h after infection. Furthermore, anti-IFN treatment in 3-week-old mice infected with HSV-1(35) led to the development of clinically apparent corneal disease which subsequently progressed to stromal keratitis in the majority of recipients. These results indicate that the striking difference in the capacity of HSV-1(35) and HSV-1(RE) to induce corneal disease was related to the inherently greater sensitivity of strain 35 to IFN-alpha/beta produced by the host in response to infection.This publication has 32 references indexed in Scilit:
- Activation of the ppp(A2'p)nA system in interferon-treated, Herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNaseEuropean Journal of Biochemistry, 1984
- Formation of Non-infective Herpesvirus Particles in Cultured Cells Treated with Human InterferonJournal of General Virology, 1984
- Effect of cloned human interferons on the replication of and cell fusion induced by herpes simplex virusVirus Research, 1984
- Comparative Neurovirulence of Herpes Simplex Virus Type 1 Strains After Peripheral or Intracerebral Inoculation of BALB/c MiceInfection and Immunity, 1983
- Differences in Neurovirulence among Isolates of Herpes Simplex Virus Types 1 and 2 in Mice using Four Routes of InfectionThe Journal of Infectious Diseases, 1981
- Marrow-dependent cells depleted by 89Sr mediate genetic resistance to herpes simplex virus type 1 infection in miceInfection and Immunity, 1980
- Strain characteristics and features of ocular infection of herpes simplex virus type 1 isolatesMedical Microbiology and Immunology, 1979
- The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in miceEpidemiology and Infection, 1978
- Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses.The Journal of Experimental Medicine, 1976
- THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITISThe Journal of Experimental Medicine, 1964